HGF and cancer: Although HGF/c‐MET pathway was deemed as a promising therapeutic target, numerous investigations have proven that inhibition of HGF or c‐Met TKI was not an effective and practical therapeutic strategy in suppressing multiple human cancers.60, 61, 62, 63